hSNF2H Inhibitors

The class of hSNF2H Inhibitors comprises a diverse range of compounds that indirectly influence the function of hSNF2H, a chromatin remodeling protein. These inhibitors primarily target processes related to chromatin structure modification, DNA repair, and cell cycle regulation. Compounds such as Trichostatin A, Vorinostat, and Valproic acid are histone deacetylase inhibitors that can alter chromatin structure, which is crucial for hSNF2H's role in nucleosome spacing and DNA accessibility. By modifying histone acetylation levels, these compounds can indirectly impact the function of hSNF2H in chromatin remodeling.

Additionally, inhibitors like 5-Azacytidine and Hydroxyurea target DNA methylation and DNA repair mechanisms, respectively. These alterations in DNA repair and replication processes can indirectly influence the function of hSNF2H in maintaining genome integrity. DNA damage response inhibitors such as Olaparib and Cisplatin, which interfere with PARP activity and form DNA adducts, respectively, can also affect the DNA repair pathways where hSNF2H is involved. Similarly, Mimosine, Camptothecin, and Etoposide, which disrupt DNA replication and topoisomerase activity, potentially affect hSNF2H's role in chromatin remodeling during DNA replication and repair.